Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,994 public trials 1,209 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)

NCT02817633

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +26 more
Locations
  • GSK Investigational Site Goodyear, Arizona, United States
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
View all 89 locations
View Trial Details
Active, Not Recruiting

Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)

NCT04385277

Conditions
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neoplasms, +9 more
Locations
  • Banner Children's at Desert Mesa, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 77 locations
View Trial Details
Active, Not Recruiting

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

NCT04056247

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations
  • Birmingham VAHCS Birmingham, Alabama, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Florida Cancer Specialist and Research Institute Orlando, Florida, United States
View all 41 locations
View Trial Details
Active, Not Recruiting

Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in Melanoma

NCT04139902

Conditions
Melanoma, Melanoma Stage III, Melanoma Stage IV, +11 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme

NCT02685605

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • Barrow Neurological Institute (SJHMC) Phoenix, Arizona, United States
  • Stritch School of Medicine Loyola University Maywood, Illinois, United States
  • Long Island Jewish Medical Center, North Shore University Hospital Lake Success, New York, United States
  • Lenox Hill Hospital, Hofstra Northwell School of Medicine New York, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM

NCT03862430

Conditions
Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations
  • Center for Neurosciences Tucson, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • UC Irvine Health- Chao Family Comprehensive Cancer Center Orange, California, United States
  • Providence St. John's Cancer Institute Santa Monica, California, United States
View Trial Details

Related conditions